Explore Our Library of Biomanufacturing Resources & Technical Data

Application Notes

OptiVERO – Expansion of VERO Cells Without Serum in Chemically Defined Cell Culture Media

OptiVERO – Virus Production Using VERO Cells in Flasks without Serum in Chemically Defined Cell Culture Media Application Note

OptiVERO – Virus Production Using VERO Cells with Microcarriers Without Serum in Chemically Defined Cell Culture Media

Blog

How Regulatory Bodies Are Driving the Shift to Animal-Origin-Free Solutions in Cell Therapy and Vaccine Development

Recombinant Virus Platforms are Out in Front in the Race to Develop Vaccines Against SARS-CoV-2 and COVID-19 Disease

SARS-CoV2 and Influenza – Double Threat

Solving the Vaccine Supply Challenge

Why Do Some Biologics Cross the Finish Line—While Others Crash and Burn?

Data Sheets

OptiVERO – Data Sheet

Journal Articles (DOI Links)

Formulation and Production of a Blood-free and Chemically Defined Virus Production Media for VERO Cells

Posters

Advancing Vaccine Excellence

Product Brochures

InVitria Product Catalog – 2025

Use Guidelines

OptiVERO – Guidelines for Use

Webinar

Accelerating Vaccine Development Through Use of Blood-Free Components

White Papers

Emergence of Blood-Free Recombinant Human Albumin

VERO Expansion in the iCellis® Bioreactor with Chemically Defined and Blood Free Virus Production Media